Navigation Links
Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
Date:6/19/2013

emissions lasting in excess of two years in the great majority of patients treated."  

Study participants were enrolled selected to receive either ibrutinib 420 mg (n=51) or 840 mg (n=34) as a once-daily, oral monotherapy. Both doses were associated with overall response rates of 71 percent. Del17p patients had an overall response rate of 68 percent. Two patients in the 420 mg dose arm had complete responses and 34 patients had partial responses. Across all relapsed or refractory patients, including the high risk patients, the estimated progression-free survival at 26 months was 75 percent. An additional 20 percent of patients treated with the 420 mg dose and 15 percent of patients taking the 840 mg dose achieved a partial response accompanied by lymphocytosis, an elevated blood lymphocyte count.

The majority of adverse events (AEs) observed in the study were considered to be Grade 1 or 2 in severity, including diarrhea, infections and fatigue. A total of six patients taking ibrutinib experienced an AE leading them to discontinue treatment with the drug. Severe AEs observed during the treatment period include pneumonia and dehydration (12 percent and six percent, respectively), as well anemia, neutropenia and thrombocytopenia (six percent, 15 percent and six percent, respectively). Grade 3-4 hematological toxicities were not common.

Data from this study were presented at the annual meeting of the American Society of Hematology in December 2012.

Study Design
The Phase 1b/2, open-label, multicenter study was designed to determine the safety, efficacy, pharmacokinetics and pharmacodynamics of ibrutinib in patients with relapsed or refractory CLL. The primary objective of the study was to determine the safety of the two fixed-dose regimens of ibrutinib, assessed by evaluating the frequency and severity of AEs. Secondary efficacy endpoints included: overall response rate, progression-free survival and an exploratory endpoint of overa
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
4. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
5. Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
6. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
7. Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor
8. Ibrutinib Expanded Access Program Open to Eligible U.S. Patients with Relapsed or Refractory Mantle Cell Lymphoma
9. Ibrutinib Phase 2 Data: Analyses Show Efficacy with Ibrutinib Monotherapy in Patients with Relapsed or Refractory Mantle Cell or Diffuse Large B-cell Lymphoma
10. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
11. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Decision ... colitis (CD/UC) patients eligible for biologic therapy, ... a biologic. Surveyed gastroenterologists cite patients, discomfort ... for low penetration rates, followed by cost-related ... UC patients receiving biologics, Janssen Biotech,s Remicade ...
(Date:9/17/2014)... , Sept. 17, 2014 ACIST Medical Systems, ... leader of advanced imaging modalities for cardiology, showcased the ... two live cases at the Transcatheter Cardiovascular Therapeutics meeting ... were presented from Medstar Washington Hospital Center ( ... Medical Center ( New York, NY ). ...
(Date:9/17/2014)... , Sept. 17, 2014  Bayer HealthCare will ... Hemophilia Foundation,s 66 th Annual Meeting, which takes ... D.C.  The data, which will be shared through poster ... and patient care. Data will be presented in a ... into treatment modalities in hemophilia A patients, Bayer is ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3ACIST Launches HDi High-Definition IVUS 2ACIST Launches HDi High-Definition IVUS 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4
... Nov. 1, 2010 Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostics ... to serving the healthcare needs of women, today ... Society of Breast Surgeons (ASBS) MammoSite® Breast Brachytherapy ...
... Nov. 1, 2010 Inovonics ( http://www.inovonics.com ), the ... commercial and life safety applications, today announced the ... sensor solution designed specifically to meet the unique ... motion-sensing technology, the EN1240 offers a significant advancement ...
Cached Medicine Technology:Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 3Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 2Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 3Inovonics Delivers Passive Wireless Sensor for Monitoring Senior Care Resident Activity 4
(Date:9/18/2014)... Fremont, CA (PRWEB) September 18, 2014 ... service was recognized by the Accrediting Commission of ... 18. The accrediting body awarded Unitek College’s community ... 2014 ACCSC Excellence in Community Service Award. ... by empowering educational service-learning opportunities through our Community ...
(Date:9/18/2014)... Salt Lake City, Utah (PRWEB) September 18, 2014 ... childhood. Now Spoonful of Comfort, an online food delivery service ... , New Country Fresh Tomato Basil soup is a ... soup begins, of course, with a tangy tomato base, then ... rich asiago and parmesan cheeses. A flashback to childhood has ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 According to the ... from eczema, with many of them being children. In fact, ... diagnosed as babies and children. The millions of children who ... be brought on by eczema. A new book has been ... they are and to find relief from the condition over ...
(Date:9/18/2014)... 2014 SpineFrontier is expanding its ... partners in Less Exposure Surgery Technology by hiring ... an extensive education curriculum and trained sales representatives ... in Organizational Leadership, and has educated and trained ... Bringing her to the team is a big ...
(Date:9/18/2014)... First Choice Emergency Room , the largest ... States, named Douglas J. Harrison, DO as the Medical ... “We are pleased to welcome Dr. Harrison to his ... Missouri City-Lakes facility,” said Dr. James M. Muzzarelli, Executive ... Dr. Harrison received his undergraduate degree from The University ...
Breaking Medicine News(10 mins):Health News:Unitek College Receives Award for Community Service Initiatives 2Health News:Unitek College Receives Award for Community Service Initiatives 3Health News:Unitek College Receives Award for Community Service Initiatives 4Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:New Book Helps Millions of Children Deal With The Emotional Pains of Suffering From Eczema 2Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:First Choice Emergency Room Announces Dr. Douglas J. Harrison as Medical Director of Missouri City - Lakes, Texas Facility 2
... In recent decades, there have been periodic reports of a ... ostensibly been on the rise, accompanied by increases in testicular ... opening of the urethra is on the underside, rather than ... conditions have been termed testicular dysgenesis syndrome. Environmental chemicals ...
... National Smile Month , , CHICAGO, June 5 ... is important that dental coverage is part of an overall ... important, according to a new public opinion survey commissioned by ... Alliance Foundation, and conducted by Harris Interactive(R), was released today ...
... damage never goes away so protect kids from the start, ... people, especially children, love to be out in the summer ... good tan. , "Remember that if you form a ... a pediatrician and researcher at Lucile Packard Children,s Hospital, said ...
... 5 Inverness Medical Innovations (NYSE: IMA ... reached agreement on a proposal for Inverness to acquire ... London, England, is a leading European supplier of drugs ... of approximately 47.5 million pounds Sterling (or approximately $76 ...
... June 5 Baylor University Medical Center at ... with GE Healthcare and BrainLAB to open technically advanced neurosurgery ... real-time, intra-operative images of the brain during surgery. The $16.5 ... BrainSUITE(R) iMRI and GE Healthcare MR Surgical Suite. , ...
... ... today they have mutually decided to terminate their contractual relationship. Effective as of June ... retained to provide ongoing group purchasing and supply chain management services. , ... Brentwood, Tenn. and Hemet, Calif. ...
Cached Medicine News:Health News:Hypospadias, a birth defect of the male urethra, is not increasing in New York state 2Health News:New Survey Shows Americans Strongly Support Guaranteed Dental Coverage in Healthcare Reform 2Health News:Wear Sunscreen for Lifelong Benefits 2Health News:Inverness Medical Innovations Proposes to Acquire Concateno plc 2Health News:Inverness Medical Innovations Proposes to Acquire Concateno plc 3Health News:Baylor Dallas Opens Nation's First Neurosurgical OR Suite Featuring BrainSUITE iMRI, GE Healthcare MR Surgical Technology 2Health News:QHR and Valley Health Amicably Part Ways 2
Helmer's Horizon Series line of refrigerators are designed specifically for the cost conscious buyer. This line offers outstanding performance, quality, and the features you need to ensure the safety...
... the i.Series refrigerator iB125, ... for the blood bank. ... than ever before, i.Series ... at the forefront of ...
... for the precise requirements of blood ... Blood Bank Equipment meets American Association ... Red Cross (ANRC) and U.S. Food ... storage freezers, and platelet incubators feature ...
... Designed for the precise requirements ... Thermo Forma Blood Bank Equipment meets ... American National Red Cross (ANRC) and ... standards. Refrigerators, storage freezers, and platelet ...
Medicine Products: